Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
Saved in:
| Title: | Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform. |
|---|---|
| Authors: | Singh-Phulgenda, Sauman1,2 (AUTHOR) sauman.singh@iddo.org, Kumar, Rishikesh3 (AUTHOR), Dahal, Prabin1,2 (AUTHOR), Munir, Abdalla4 (AUTHOR), Rashan, Sumayyah1,2 (AUTHOR), Chhajed, Rutuja1,2 (AUTHOR), Naylor, Caitlin1,2 (AUTHOR), Maguire, Brittany J.1,2 (AUTHOR), Siddiqui, Niyamat Ali3 (AUTHOR), Harriss, Eli5 (AUTHOR), Rahi, Manju6 (AUTHOR), Alves, Fabiana7 (AUTHOR), Sundar, Shyam8 (AUTHOR), Stepniewska, Kasia1,2 (AUTHOR), Musa, Ahmed4 (AUTHOR), Guerin, Philippe J.1,2 (AUTHOR), Pandey, Krishna3 (AUTHOR) sauman.singh@iddo.org |
| Source: | PLoS Neglected Tropical Diseases. 4/16/2024, Vol. 18 Issue 4, p1-27. 27p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
